Skip to main content
. 2022 Nov 7;44(1):1886–1896. doi: 10.1080/0886022X.2022.2142139

Table 1.

Baseline characteristics of elderly patients with AKD.

Variables Training cohort
External validation cohort
Survival (n = 1876) Death (n = 790) P-value Survival (n = 363) Death (n = 172) P-value
Demographic            
 Age, years 72.7 [66.6, 80.1] 76.1 [68.7, 82.8] <0.001 70.0 [64.0, 75.0] 72.0 [66.0, 79.0] 0.002
 Gender, n (%)     0.131     0.569
  Male 1087 (57.9) 432 (54.7)   200 (55.1) 100 (58.1)  
  Female 789 (42.1) 358 (45.3)   163 (44.9) 72 (41.9)  
 Ethnicity, n (%)     0.015     0.006
  White 1275 (68.0) 517 (65.4)   264 (72.7) 147 (85.5)  
  Black 196 (10.4) 69 (8.7)   60 (16.5) 11 (6.4)  
  Asian 48 (2.6) 14 (1.8)   3 (0.8) 1 (0.6)  
  Other 357 (19.0) 190 (24.1)   36 (9.9) 13 (7.6)  
 BMI (kg/m2) 29.0 [24.8, 34.2] 27.7 [23.8, 33.0] <0.001 29.9 [25.8, 36.0] 28.3 [24.6, 33.5] 0.018
Disease severity            
 Aki stage, n (%)     0.583     0.141
  I 1452 (77.4) 598 (75.7)   301 (82.9) 150 (87.2)  
  II 389 (20.7) 178 (22.5)   58 (16.0) 18 (10.5)  
  III 35 (1.9) 14 (1.8)   4 (1.1) 4 (2.3)  
 GCS 10.0 [6.0, 13.0] 7.0 [3.0, 11.0] <0.001 8.0 [3.0, 13.0] 8.0 [3.0, 13.0] 0.75
 Delta GCS 5.0 [2.0, 9.0] 7.0 [4.0, 12.0] <0.001 4.0 [0.0, 8.0] 1.0 [–2.0, 5.0] <0.001
 SOFA 8.0 [5.0, 11.0] 9.0 [7.0, 12.0] <0.001 8.0 [5.0, 10.0] 7.0 [5.0, 10.0] 0.385
 Delta SOFA –2.0 [–4.0, 0.0] 0.0 [–3.0, 1.8] <0.001 –1.0 [–4.0, 1.0] 1.0 [–1.2, 4.0] <0.001
Comorbidities, n (%)            
 Sepsis 1706 (90.9) 756 (95.7) <0.001 107 (29.5) 71 (41.3) 0.009
 Hypertension 964 (51.4) 372 (47.1) 0.047 60 (16.5) 33 (19.2) 0.525
 Diabetes mellitus 757 (40.4) 291 (36.8) 0.098 53 (14.6) 35 (20.3) 0.121
 Cerebrovascular disease 116 (6.2) 37 (4.7) 0.153 35 (9.6) 9 (5.2) 0.118
 CHF 435 (23.2) 201 (25.4) 0.231 45 (12.4) 30 (17.4) 0.151
 CKD 554 (29.5) 273 (34.6) 0.012 45 (12.4) 26 (15.1) 0.466
Interventions, n (%)            
 MV 1849 (98.6) 780 (98.7) 0.866 65 (17.9) 44 (25.6) 0.052
 RRT 311 (16.6) 228 (28.9) <0.001 9 (2.5) 2 (1.2) 0.499
 Renal toxic drugs 1811 (96.5) 767 (97.1) 0.541 54 (14.9) 46 (26.7) 0.002
 Vasopressor use 1388 (74.0) 683 (86.5) <0.001 124 (34.2) 56 (32.6) 0.789
Vital signs            
 Heart rate (bpm) 85.1 [77.0, 94.3] 88.0 [78.4, 97.5] <0.001 91.3 [80.4, 104.8] 88.9 [77.6, 98.6] 0.01
 Delta heart rate (bpm) –15.7 [–23.0, −8.6] –17.9 [–30.1, −8.4] <0.001 –21.8 [–34.3, −9.1] –17.2 [–26.8, −6.4] 0.002
 SBP (mmHg) 118.1 [109.5, 129.4] 112.7 [105.6, 123.2] <0.001 116.0 (17.9) 115.0 (15.1) 0.499
 Delta SBP (mmHg) –27.7 [–38.0, −19.3] –33.1 [–46.6, −22.5] <0.001 –20.1 [–34.3, −3.2] –28.6 [–43.0, −13.8] <0.001
 DBP (mmHg) 59.2 [54.2, 65.1] 57.0 [52.1, 62.4] <0.001 62.7 [56.3, 69.8] 60.3 [55.4, 66.3] 0.003
 Delta DBP (mmHg) –16.2 [–21.8, −11.3] –18.5 [–24.9, −12.7] <0.001 –15.5 [–25.2, −8.8] –17.3 [–27.3, −10.5] 0.139
 MAP (mmHg) 76.4 [71.6, 82.5] 73.3 [69.4, 79.0] <0.001 76.9 [68.7, 84.7] 74.5 [67.7, 81.4] 0.035
 Delta MAP (mmHg) –20.0 [–26.5, −13.9] –22.4 [–32.0, −16.2] <0.001 –16.2 [–25.4, −6.6] –18.3 [–29.1, −9.4] 0.023
 Temperature (°C) 37.0 (0.5) 36.9 (0.5) <0.001 37.0 [36.7, 37.3] 36.7 [36.4, 37.2] 0.001
 Delta Temperature (°C) –0.6 [–0.9, –0.3] –0.6 [–1.0, –0.3] 0.516 –0.6 [–1.1, –0.2] –0.4 [–1.0, 0.0] 0.063
 Respiratory rate (bpm) 20.3 (3.1) 21.0 (3.4) <0.001 19.8 [17.2, 23.3] 20.0 [17.4, 24.0] 0.359
 Delta Respiratory rate (bpm) –7.1 [–9.7, –4.9] –7.8 [–11.2, –5.3] <0.001 –6.7 [–10.9, –3.0] –5.1 [–10.2, –1.6] 0.038
 SpO2 (%) 96.9 [95.9, 97.9] 97.0 [95.8, 97.9] 0.958 96.9 [95.2, 98.2] 96.9 [95.2, 98.7] 0.345
 Delta SpO2 (%) –5.1 [–7.3, –3.2] –6.3 [–12.7, –3.8] <0.001 –4.9 [–8.5, –2.0] –7.0 [–14.9, –3.4] <0.001

AKI: acute kidney injury; CHF: congestive heart failure; CKD: chronic kidney disease; DBP: diastolic blood pressure; GCS: Glasgow coma scale; MAP: mean artery pressure; MV: mechanical ventilation; RRT: renal replacement therapy; SBP: systolic blood pressure; SOFA: sequential organ failure assessment; SpO2: peripheral oxygen saturation.